Effects of zonisamide, an anti-parkinsonian drug, on cognition and BPSD in DLB patients: A post-hoc analysis of DLB Ph2 study

Murata, M; Odawara, T; Konishi, O; Nakamura, M; Kosaka, K

MOVEMENT DISORDERS, 2017; 32 ( ):